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Abstract 
 
Basophils are effector cells most often associated with airway inflammation in patients with asthma and can 
have an important role in the initiation of  Th2 inflammation, as these cells may be activated directly by tissue 
cytokines (IL-25, IL-33 and TSLP) released by epithelial cells in response to damage signals from allergens, 
bacterials, virus or pollutants.  
 
We investigated whether IL-25, IL-33 and TSLP receptors expression levels on basophil membrane are 
associated with  asthma phenotype. 
 
24 patients with asthma (12 eosinophilic, 12 non eosinophilic) have been enrolled in the study. Basophils 
membrane expression of IL25 R, TSLP R and IL33 R was analyzed before and after IgE, fMLP, LPS, LTA-SA 
(Lipoteicoic Acid from S. Aureus) stimulation and correlated with FEV1 of each patient. 
 
Following LPS stimulation a significant increase in IL25 R was observed in eosinophilic (p=0.001) but not in 
non eosinophilic asthma. IgE stimulation significantly increased IL25 R expression on basophils membrane, in 
both eosinophilic and non eosinophilic asthma (p= 0.001 and p= 0.001, respectevely), the percentual increase 
being greater in eosinophilic compared to non-eosinophilic asthma (p=0.007). 
 
IL33 R and TSLP R expression on unstimulated basophils  were inversely correlated with FEV1 in eosinophilic 
asthma  ( r= -0.45, p = 0.04 and r = -0.70, p = 0.01, respectively). 
 
In conclusion, in eosinophilc asthma, airway obstruction is inversely correlated to the membrane expression 
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of TSLP and IL33 receptors on basophils. Whether the expression of epithelial cytokines on basophils 
membrane may be used as biomarker of severe eosinophilic asthma remains to be investigated. 
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1. Introduction 
 
Basophils have an important role in the development of  airway  inflammation  commonly found in 
bronchial biopsies of asthmatic patients, where their number has been reported to be significantly 
higher than in healthy subjects (Schwartz et al.,2015). Basophils are not only effector cells, which 
release  vasoactive amines and lipid metabolites through IgE and chemokine stimulation, but they 
play a role in the initiation and  amplification of  Th2 inflammation, as these cells may be activated 
directly by cytokines, such as IL25, IL33 and Thymic Stromal Lymphopoietin(TSLP), released by the 
airway epithelial cells in response to damage signals from allergens, bacteria, virus or pollutants 
(Licona-Limón et al.,2013). Thus, basophils are involved in the so-called ‘Th2-high’ expression 
profile of the specific phenotype of asthma  which is associated with high levels of circulating IgE, 
atopy, and eosinophilia(Bhakta and  Woodruff, 2011).  
 
Our hypothesis is that basophils membrane expression  of epithelial cytokines receptors could be 
increased in the eosinophilic phenotype of asthma. To test this hypothesis we used flow cytometry 
to compare spontaneous and stimulated expression of IL25, TSLP and IL33 receptors on basophils 
from patients with eosinophilic and non eosinophilic asthma, compared to normal controls. 
 
2. Materials and Methods 
 
2.1. Patients 
 
Twenty-four consecutive patients in charge to Outpatient Asthma Clinic since at least 1 year, who 
had received  a clinical diagnosis of asthma and well documented  improvement in FEV1 of more 
than 12% and 200 mL after 200 μg inhaled salbutamol or a provocative concentration of inhaled 
methacholine needed to reduce FEV1 by 20% (PC20) of 8 mg/mL or less in the 12 months before 
study entry were admitted to the study. Twelve patients (50%) were selected based on  an asthma-
related peripheral blood eosinophil count of 0·3×10⁹ per L or more at study entry or in the previous 
6 months. Sample size was calculated assuming a power of 0.8. 
 
Spirometry, exhaled nitric oxide measurement and blood sample for basophil activation test were 
obtained in all the patients, who gave their informed consent to participate to the study, which was 
approved by the Institutional Review Board. 
 
Spirometry was carried out by using Biomedin Instrument  (Padua, Italy) in accordance with the 
American Thoracic Society criteria (ATS/ERS Task Force, 2005). Exhaled nitric oxide (FENO) was 
measured by using a portable electrochemistry-based sensor (NIOX MINO; Aerocrine AB, Solna, 
Sweden) according to  the recommendation of American Thoracic Society/European Respiratory 
Society (ATS/ERS Recommendations, 2005) and the results were presented as parts per billion 
(ppb). Briefly, the patients were asked to exhale, then inhale through the device, and exhale steadily 
for 10 seconds at a flow rate of 50 mL/s and at a pressure of 10 cm H2O. The flow rate and pressure 
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were automatically controlled, and any incorrect performance was automatically rejected by the 
device. The measurements were taken with the participants in a sitting position in the morning, 
before the lung function tests and at least  1 hour after their breakfast. 
 
2.2. Basophil activation test (BAT) 
 
BAT  was performed according to previously reported technique (Hoffmann et al., 2015). Briefly, 
endotoxin-free heparinized whole-blood samples were obtained from asthmatic patients. Cells 
were challenged with 100 µl of anti-IgE (10 µg/mL; clone G7-18 BD Bioscience, USA), fMLP (0.5 
µg/ml, Sigma Aldrich, Italy), or TLR ligands (lipotheichoic acid from Staphylococcus aureus (LTA-
SA) 1 µg/ml, InvivoGen, USA, and lipopolysaccharide from Escherichia Coli (LPS) 1 µg/ml, Sigma 
Aldrich, Italy) for 20 minutes at 37°C in a warm bath (optimal stimulation time were assessed in 
previous experiments). The optimal stimulation concentrations of the anti-IgE, fMLP and TLRs 
ligands were established in preliminary experiments. As a negative control, Tyrode buffer (Sigma 
Aldrich, Italy) with 20µM HEPES and 7.5% NaHCO3, pH 7.4 was used to assess the spontaneous 
expression of the different markers. The reactions were terminated by chilling the cells on ice. 
 
2.3. Immunophenotyping and flow cytometric analyses 
 
Basophils were stained with anti-human FcԑRIα-Pacific Blue (BioLegend, San Diego, CA), anti-
human CD63-FITC (clone H5C6, BD Biosciences), anti-human CD203c-APC (clone NP4D6 Biolegend, 
San Diego, CA), anti-human TSLP R-PE (Biolegend, San Diego, CA), anti-human IL33 R-PE (MBL, 
Leuven, Belgium), and anti-human IL25 R-APC (R&D Systems, Minneapolis, USA) for 20 minutes on 
ice. The flow cytometric analyses was performed on a Navios Beckman Culter Cytometer. Side 
scatter and anti-IgE+/CD203c+ staining were applied to gate out at least 500 basophils. TSLP R, 
IL33 R and IL25 R positivity was set on basophils with a fluorescence intensity that was above the 
level of the 99th percentile of a fluorescence-minus-one (FMO) sample.  
 
2.4. Statistics 
 
Statistical analysis was performed by  using  GraphPad Prism 4.0c, GraphPad Software, Inc, CA, USA. 
Data are given as means ±  S.E.M. and the increase of expression is reported in terms of percent of 
baseline [(post stimulation- pre stimulation)/pre stimulation]*100.  Comparisons of paired data 
were carried out by using the t-test for paired data. In all the other calculations, an unpaired t test 
or the Mann-Whitney test was used. Correlation was evaluated by calculating Pearson correlation 
coefficient. A  P values < 0.5  was considered significant. 
 
3. Results 
 
Basophils membrane expression of  IL25, TSLP and IL33 receptors  was not significantly different  
in asthmatic and  controls (data not shown).  
 
Clinical and demographic characteristics of the patients are reported in Table 1. Patients with 
eosinophilic asthma were significantly younger  than patients with non eosinophilic asthma 
(42.58±6.38 vs 63.17±2.84 years, p= 0.007 ). Most patients with eosinophilic asthma were atopic  
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(9/12) and had FENO values >35 ppb (9/12) compared to patients with non eosinophilic asthma 
(3/12, p=0.014). 
 
Table 1 Clinical and demographic characteristics of the patients 
 
Before stimulation, no significant difference in  receptors expression was observed between 
patients with eosinophilic and  non eosinophilic asthma (IL33 R: 2.30 ± 0.54 vs 1.30 ± 0.38, p=0.08; 
TSLP R: 6.34 ± 0.96  vs 4.98 ± 1.20, p=0.07; IL25 R: 10.63 ± 1.89 vs 19.55 ± 5.55, p=0.09). 
 
Following LPS stimulation a significant increase in IL25 R was observed in eosinophilic asthma 
(from 10.63 ± 1.89 to 15.74±2 % of IL25 R +cells, p=0.001) but not in non eosinophilic asthma (see 
Fig. 1). 
 
 EOSINOPHILIC 
ASTHMA 
NON 
EOSINOPHILIC 
ASTHMA 
P VALUE 
Number of patients 12 12  
Age median, years (range) 42.58 ± 6.38 63.17 ± 2.84 0.007 
Male, n (%) 7 (58.3) 5 (41.7) 0.414 
Atopy, n(%) 9 (75.0) 3 (25.0) 0.014 
Early onset asthma, n (%) 5 (41.7) 2 (16.7) 0.177 
Asthma classification, n (%) 
Mild 
Moderate 
Severe 
 
4 (33.3) 
5 (41.7) 
3 (25.0) 
 
2 (16.7) 
4 (33.3) 
6 (50.0) 
 
0.345 
0.673 
0.51 
Frequent exacerbators, n (%) 6 (50.0) 7 (58.3) 0.205 
Rhinitis, n (%) 4 (33.3) 4 (33.3) 1 
CRSNP, n (%) 1 (8.3) 2 (16.7) 0.537 
CRSWNP, n (%) 7 (58.3) 6 (50.0) 0.681 
CTS therapy 3 (25.0) 6 (50.0) 0.205 
FeNO>35 ppb 9 (75.0) 3 (25.0) 0.014 
FeNO (mean ± SEM) 51.33 ± 8.89 31.61 ± 7.27 0.093 
Eosinophils count (mean ± 
SEM) 
733.2 ± 95.9 190.8 ± 27.9 <0.0001 
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Fig. 1. Percentage of IL25 R  positive basophils  before and after LPS stimulation in eosinophilic and 
non eosinophilic asthma. 
 
 
Fig. 2. Panel A) Percentage of IL25 R positive basophils before and after IgE stimulation in 
eosinophilic and non eosinophilic asthma patients. Panel B)  IL25 R increase (in percent of 
baseline) in eosinophilic and non eosinophilic asthma patients. 
 
IgE stimulation significantly increased IL25 R expression on basophils membrane, in both 
eosinophilic and non eosinophilic asthma  (eosinophilic asthma: from 10.63 ± 1.89 to 38.29 ±7.23, 
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p= 0.001; non eosinophilic asthma: from 19.55 ± 5.55 to 31.48 ± 5.03, p= 0.001), the percentual 
increase being greater in eosinophilic compared to non-eosinophilic asthma (319.01 ± 65.83 vs 
103.43 ± 30.31 % of baseline, p=0.007; Fig. 2, panel A and B). 
 
fMLP and LTA-SA stimulation did not change the expression of  IL33, TSLP and IL25 receptors on 
basophils membrane.  
 
IL33 R and TSLP R expression on unstimulated basophils  were inversely correlated with FEV1 in 
eosinophilic asthma  ( r= -0.45, p = 0.04 and r = -0.70, p = 0.01, respectively, see Fig. 3, panel A and 
B). 
 
 
Fig. 3. Panel A) Correlation between baseline  IL33 R and FEV1 in patients with eosinophilic 
asthma. Panel B) Correlation between baseline TSLP R  and FEV1 in patients with 
eosinophilic asthma. 
 
4. Discussion 
 
Baseline expression of the three epithelial cytokines  receptors on basophils membrane was not 
different between  healthy controls and asthmatic patients, either with eosinophilic or non 
eosinophilic asthma.  
 
Nevertheless, an inverse relationship between FEV1 and basophils membrane expression of TSLP 
and IL 33 receptors was observed  in eosinophilic asthma. This finding suggests that the expression 
of TSLP and IL33 receptors on membrane of peripheral basophils mirrors the interaction between  
airway epithelial cells  and basophils, which play a role in  the pathogenesis of Th2 chronic airway 
inflammation underlying airways obstruction of eosinophilic asthma. Basophils are well known to 
be involved not only  in the early asthmatic response, with release of  histamine and cysteinyl 
leukotrienes, which contribute to bronchoconstriction, but also in chronic airway inflammation. 
 
Both TSLP and IL33  interact with innate immunity cells, such as basophils, mast cells and innate 
lymphocytes type 2 (ILC2) promoting the production and release of Th2 cytokines by these cells 
(Salter et al., 2016). 
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The mechanisms  of basophils membrane expression of epithelial cytokines  receptors are not 
completely known. It has been shown that TSLP released by  airway epithelial cells  may upregulate 
epithelial cytokines receptors on basophils membrane (Wang et al., 2009). Moreover, allergen 
provocation has been shown also to increase the expression of epithelial cytokine  IL25 and its 
receptor in the asthmatic bronchial mucosa (Corrigan et al., 2011). Different stimuli such as 
bacterial, viral, fungal infections and allergen challenges can trigger the release of IL33, which in 
turn may upregulate the expression of its receptor,  which has been shown to be increased in 
bronchial epithelial cells of asthmatic patients (Préfontaine et al., 2010). 
 
As epithelial derived cytokines, IL25, IL33 and TSLP,  are considered strategic in driving Th2 
response through the release of classical Th2 cytokines such as IL4, IL5 and IL-13 by Th2 CD4+ cells 
(Soumenlis et al., 2002)  as well by innate type 2  lymphocytes (Saenz et al., 2010) we expected to 
find higher expression of epithelial cytokines receptors on basophils membrane of eosinophilic 
compared to non eosinophilic asthma. Unexpectedly we did not find any difference  in baseline 
basophil receptors expression  between patients with eosinophilic and  non eosinophilic asthma, at 
least in baseline conditions. Actually, following LPS stimulation IL25 R  was more expressed on 
basophils membrane of eosinophilic than non eosinophilic asthma and, following IgE stimulation, 
IL25 R expression increased more, in percent of baseline, on basophils membrane of  eosinophilic 
compared to non-eosinophilic asthma. The meaning of this observation is not clear, as the baseline 
membrane expression of IL25 R was lower in eosinophilic asthma than in non eosinophilic asthma.  
 
In conclusion, in eosinophilc asthma, airway obstruction is inversely correlated to the membrane 
expression of TSLP and IL33 receptors on peripheral basophils. Whether the expression of 
epithelial cytokines on basophils membrane may be used as biomarker of severe eosinophilic 
asthma remains to be investigated. 
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